ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,759Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 973

$546K Total Retail Price of All Prescriptions

Rank: 111 out of 973

487 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 8,636 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 462 414 1 1
FUROSEMIDE 451 379 2 6
HYDROCODONE-ACETAMINOPHEN 443 284 S3 3 4
LISINOPRIL 386 330 4 3
LEVOTHYROXINE SODIUM 335 290 5 2
OMEPRAZOLE 333 236 6 5
POTASSIUM CHLORIDE 304 255 7 9
METOPROLOL TARTRATE 296 242 8 13
AMLODIPINE BESYLATE 272 222 9 7
ATENOLOL 257 222 10 16
WARFARIN SODIUM 240 181 11 10
MELOXICAM 221 197 12 23
CITALOPRAM HBR 188 164 13 14
ZOLPIDEM TARTRATE 184 106 14 20
GABAPENTIN 165 91 15 12
METFORMIN HCL 141 135 16 8
GLYBURIDE 132 132 R 17 59
CYCLOBENZAPRINE HCL 119 65 R 18 42
DIGOXIN 116 102 19 32
PANTOPRAZOLE SODIUM 114 101 20 37
SERTRALINE HCL 112 65 21 21
POLYETHYLENE GLYCOL 3350 111 107 22 36
HYDROCHLOROTHIAZIDE 103 100 23 11
AZITHROMYCIN 103 72 23 47
FENTANYL 100 45 S2 25 53
CEPHALEXIN 100 67 25 75
NAMENDA 100 99 25 31
BYSTOLIC 99 73 28 110
TAMSULOSIN HCL 97 91 29 28
METOPROLOL SUCCINATE 97 63 29 17
NEXIUM 95 41 31 30
TRIAMTERENE-HYDROCHLOROTHIAZID 83 71 32 140
CARVEDILOL 82 65 33 27
ALLOPURINOL 81 68 34 29
FLUOXETINE HCL 79 62 35 56
LOSARTAN POTASSIUM 74 61 36 19
METHOTREXATE 71 39 37 227
VENTOLIN HFA 67 37 38 180
FINASTERIDE 67 60 38 90
CLONIDINE HCL 66 25 40 67
NYSTATIN-TRIAMCINOLONE 65 48 41 206
ALENDRONATE SODIUM 64 51 42 24
DONEPEZIL HCL 61 61 43 26
ATORVASTATIN CALCIUM 60 47 44 15
CARBIDOPA-LEVODOPA 59 56 45 71
TAMOXIFEN CITRATE 58 58 46 345
FLUTICASONE PROPIONATE 58 40 46 35
RISPERIDONE 58 28 46 65
VOLTAREN 57 32 49 196
ENALAPRIL MALEATE 56 56 50 55
VENLAFAXINE HCL ER 55 37 51 95
PREDNISONE 54 46 52 33
PHENYTOIN SODIUM EXTENDED 53 37 53 141
TRAMADOL HCL 51 20 54 18
CELEBREX 51 26 54 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.